In 2021, McNally was elected a member of the National Academy of Medicine "for discovering genetic variants responsible for multiple distinct inherited cardiac and skeletal myopathic disorders and pioneering techniques for mapping modifiers of single gene disorders by integrating genomic and transcriptomic data to define the pathways that mediate disease risk and progression."

[4] While working in this role, she was named one of four recipients of the Charles E. Culpeper Foundation Scholarships in Medical Science for 1998 to study the inherited nature of human disease.

[5] McNally was eventually promoted to the rank of associate professor in medicine and human genetics in 2003[4] and elected to the American Society for Clinical Investigation.

[9] At the start of the COVID-19 pandemic, McNally collaborated with Feinberg investigators to develop an at-home COVID-19 antibody test that can determine prior exposure to the SAR-CoV-2 virus.

[10] In 2021, McNally was elected a member of the National Academy of Medicine "for discovering genetic variants responsible for multiple distinct inherited cardiac and skeletal myopathic disorders and pioneering techniques for mapping modifiers of single gene disorders by integrating genomic and transcriptomic data to define the pathways that mediate disease risk and progression.